Biohaven Pharmaceutical Holding Stock Price History
BHVN Stock | USD 44.03 0.26 0.59% |
If you're considering investing in Biohaven Stock, it is important to understand the factors that can impact its price. As of today, the current price of Biohaven Pharmaceutical stands at 44.03, as last reported on the 18th of April 2024, with the highest price reaching 45.60 and the lowest price hitting 42.55 during the day. We consider Biohaven Pharmaceutical not too volatile. Biohaven Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.0167, which signifies that the company had a 0.0167% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Biohaven Pharmaceutical Holding, which you can use to evaluate the volatility of the firm. Please confirm Biohaven Pharmaceutical's Mean Deviation of 2.58, risk adjusted performance of 0.0134, and Downside Deviation of 3.94 to double-check if the risk estimate we provide is consistent with the expected return of 0.0657%.
At this time, Biohaven Pharmaceutical's Total Stockholder Equity is very stable compared to the past year. As of the 18th of April 2024, Other Stockholder Equity is likely to grow to about 73.8 M, while Liabilities And Stockholders Equity is likely to drop about 347.2 M. . At this time, Biohaven Pharmaceutical's Price Book Value Ratio is very stable compared to the past year. As of the 18th of April 2024, Price Earnings To Growth Ratio is likely to grow to 0.14, while Price To Sales Ratio is likely to drop 8.54. Biohaven Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Biohaven |
Sharpe Ratio = 0.0167
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | BHVN | Huge Risk |
Negative Returns |
Estimated Market Risk
3.94 actual daily | 34 66% of assets are more volatile |
Expected Return
0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Biohaven Pharmaceutical is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biohaven Pharmaceutical by adding it to a well-diversified portfolio.
Price Book 10.1281 | Book Value 5.276 | Enterprise Value 3.2 B | Enterprise Value Ebitda (9.28) | Shares Float 65.9 M |
Biohaven Pharmaceutical Stock Price History Chart
There are several ways to analyze Biohaven Stock price data. The simplest method is using a basic Biohaven candlestick price chart, which shows Biohaven Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 13, 2024 | 59.75 |
Lowest Price | April 16, 2024 | 43.77 |
Biohaven Pharmaceutical April 18, 2024 Stock Price Synopsis
Various analyses of Biohaven Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Biohaven Stock. It can be used to describe the percentage change in the price of Biohaven Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Biohaven Stock.Biohaven Pharmaceutical Price Action Indicator | 0.09 | |
Biohaven Pharmaceutical Price Daily Balance Of Power | 0.09 | |
Biohaven Pharmaceutical Price Rate Of Daily Change | 1.01 |
Biohaven Pharmaceutical April 18, 2024 Stock Price Analysis
Biohaven Stock Price History Data
The price series of Biohaven Pharmaceutical for the period between Fri, Jan 19, 2024 and Thu, Apr 18, 2024 has a statistical range of 17.04 with a coefficient of variation of 10.01. The prices are distributed with arithmetic mean of 50.31. The median price for the last 90 days is 48.71.Open | High | Low | Close | Volume | ||
04/18/2024 | 44.14 | 45.60 | 42.55 | 44.03 | ||
04/17/2024 | 44.14 | 45.60 | 42.55 | 44.03 | 1,040,176 | |
04/16/2024 | 44.77 | 45.07 | 42.35 | 43.77 | 1,955,033 | |
04/15/2024 | 50.96 | 52.50 | 43.58 | 44.77 | 3,401,934 | |
04/12/2024 | 53.49 | 53.70 | 52.13 | 53.08 | 792,385 | |
04/11/2024 | 51.53 | 53.80 | 51.20 | 53.49 | 697,997 | |
04/10/2024 | 50.37 | 51.60 | 49.77 | 51.06 | 718,485 | |
04/09/2024 | 51.62 | 53.13 | 50.85 | 51.98 | 756,411 | |
04/08/2024 | 52.29 | 52.42 | 50.02 | 51.41 | 834,721 | |
04/05/2024 | 51.93 | 53.73 | 51.36 | 52.52 | 584,172 | |
04/04/2024 | 52.70 | 55.72 | 51.60 | 52.33 | 879,794 | |
04/03/2024 | 50.25 | 52.74 | 50.25 | 52.28 | 934,423 | |
04/02/2024 | 50.99 | 52.15 | 50.10 | 50.79 | 1,230,465 | |
04/01/2024 | 54.69 | 54.69 | 51.57 | 52.06 | 936,067 | |
03/28/2024 | 57.02 | 57.02 | 54.65 | 54.69 | 841,480 | |
03/27/2024 | 56.88 | 57.07 | 54.22 | 57.02 | 834,506 | |
03/26/2024 | 58.20 | 59.53 | 56.20 | 56.29 | 1,815,133 | |
03/25/2024 | 55.62 | 56.32 | 55.13 | 55.23 | 1,190,764 | |
03/22/2024 | 55.63 | 56.43 | 55.25 | 55.85 | 1,011,526 | |
03/21/2024 | 60.17 | 60.46 | 55.85 | 55.88 | 1,791,806 | |
03/20/2024 | 56.02 | 59.37 | 55.43 | 59.36 | 921,317 | |
03/19/2024 | 56.01 | 57.83 | 55.45 | 56.95 | 2,448,834 | |
03/18/2024 | 58.26 | 58.97 | 56.26 | 56.74 | 1,935,701 | |
03/15/2024 | 55.32 | 57.95 | 54.95 | 57.07 | 3,605,921 | |
03/14/2024 | 58.98 | 59.15 | 55.44 | 56.42 | 2,052,851 | |
03/13/2024 | 58.30 | 60.83 | 58.01 | 59.75 | 2,362,404 | |
03/12/2024 | 54.58 | 58.70 | 54.40 | 58.58 | 1,274,765 | |
03/11/2024 | 57.56 | 57.99 | 54.00 | 55.38 | 1,499,873 | |
03/08/2024 | 59.00 | 62.21 | 55.88 | 57.97 | 1,700,918 | |
03/07/2024 | 58.99 | 59.25 | 56.58 | 58.05 | 1,288,304 | |
03/06/2024 | 59.60 | 60.22 | 56.80 | 58.13 | 1,209,661 | |
03/05/2024 | 56.05 | 61.25 | 56.01 | 58.65 | 2,011,712 | |
03/04/2024 | 51.50 | 58.83 | 51.15 | 56.39 | 2,579,407 | |
03/01/2024 | 47.48 | 51.78 | 46.25 | 49.54 | 1,741,747 | |
02/29/2024 | 48.56 | 49.38 | 46.83 | 48.14 | 1,550,442 | |
02/28/2024 | 47.20 | 48.04 | 46.26 | 47.30 | 824,661 | |
02/27/2024 | 46.96 | 48.58 | 45.85 | 47.66 | 1,065,534 | |
02/26/2024 | 47.20 | 48.00 | 44.39 | 46.18 | 1,210,477 | |
02/23/2024 | 48.38 | 49.61 | 47.25 | 47.31 | 686,976 | |
02/22/2024 | 47.00 | 48.50 | 46.86 | 47.33 | 532,640 | |
02/21/2024 | 46.85 | 47.70 | 45.20 | 46.57 | 829,451 | |
02/20/2024 | 48.92 | 50.68 | 46.98 | 47.24 | 1,097,590 | |
02/16/2024 | 48.86 | 50.22 | 48.44 | 49.50 | 667,098 | |
02/15/2024 | 47.57 | 49.25 | 47.57 | 49.11 | 628,770 | |
02/14/2024 | 48.00 | 48.92 | 45.69 | 47.12 | 800,681 | |
02/13/2024 | 46.90 | 48.26 | 46.05 | 46.95 | 1,324,235 | |
02/12/2024 | 49.28 | 50.23 | 47.97 | 48.71 | 695,219 | |
02/09/2024 | 47.12 | 48.93 | 47.12 | 48.55 | 508,927 | |
02/08/2024 | 47.26 | 48.20 | 46.18 | 46.92 | 641,580 | |
02/07/2024 | 47.27 | 48.21 | 46.93 | 47.26 | 517,616 | |
02/06/2024 | 47.77 | 48.58 | 46.57 | 47.21 | 865,787 | |
02/05/2024 | 44.79 | 47.50 | 44.26 | 47.16 | 948,445 | |
02/02/2024 | 44.06 | 45.07 | 43.05 | 44.79 | 680,728 | |
02/01/2024 | 44.92 | 45.74 | 43.94 | 45.00 | 576,121 | |
01/31/2024 | 43.89 | 46.37 | 43.89 | 44.48 | 913,931 | |
01/30/2024 | 45.25 | 45.90 | 43.65 | 43.81 | 991,242 | |
01/29/2024 | 45.50 | 46.61 | 44.90 | 45.67 | 807,489 | |
01/26/2024 | 45.10 | 45.30 | 44.19 | 44.89 | 508,742 | |
01/25/2024 | 46.09 | 47.23 | 44.90 | 44.97 | 757,868 | |
01/24/2024 | 49.10 | 49.58 | 45.33 | 45.60 | 599,827 | |
01/23/2024 | 49.03 | 49.65 | 46.88 | 48.31 | 1,175,653 |
About Biohaven Pharmaceutical Stock history
Biohaven Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biohaven is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biohaven Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biohaven Pharmaceutical stock prices may prove useful in developing a viable investing in Biohaven Pharmaceutical
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 71.2 M | 51.9 M | |
Net Loss | -513.3 M | -538.9 M |
Biohaven Pharmaceutical Quarterly Net Working Capital |
|
Biohaven Pharmaceutical Stock Technical Analysis
Biohaven Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
Biohaven Pharmaceutical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Biohaven Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Biohaven Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biohaven to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0134 | |||
Jensen Alpha | (0.07) | |||
Total Risk Alpha | (0.26) | |||
Sortino Ratio | (0.01) | |||
Treynor Ratio | 0.0108 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Biohaven Stock analysis
When running Biohaven Pharmaceutical's price analysis, check to measure Biohaven Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohaven Pharmaceutical is operating at the current time. Most of Biohaven Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biohaven Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohaven Pharmaceutical's price. Additionally, you may evaluate how the addition of Biohaven Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Biohaven Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.73) | Return On Assets (0.46) | Return On Equity (0.84) |
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.